Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

The FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

Widaplik marks the first and only FDA-approved triple combination medication that can be used as an initial therapy for patients with hypertension who require multiple drugs to reach their blood ...

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.

A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial ...

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...

The FDA approval is based on positive results from two international phase 3 trials that compared Widaplik to dual combinations of its component drugs as well as to placebo. The results of both ...

The pill is available in a standard dose, as well as two low doses, and can be used in those initiating treatment. HealthDay News — The US Food and Drug Administration (FDA) has approved ...

WEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.